Celltrion
068270.KS
#801
Rank
HK$191.27 B
Marketcap
HK$923.47
Share price
-0.60%
Change (1 day)
-1.91%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Cash on Hand

Cash on Hand as of March 2024 : HK$5.32 Billion

According to Celltrion 's latest financial reports the company has HK$5.32 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Celltrion - Cash on Hand chart (from 2007 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31HK$3.68 B-53.92%
2021-12-31HK$7.99 B60.43%
2020-12-31HK$4.98 B17.84%
2019-12-31HK$4.22 B13.26%
2018-12-31HK$3.73 B-8.7%
2017-12-31HK$4.08 B131.83%
2016-12-31HK$1.76 B71.54%
2015-12-31HK$1.02 B22.52%
2014-12-31HK$0.83 B0.85%
2013-12-31HK$0.83 B8.02%
2012-12-31HK$0.77 B96.1%
2011-12-31HK$0.39 B-53.74%
2010-12-31HK$0.84 B473.63%
2009-12-31HK$0.14 B467.62%
2008-12-31HK$26.08 M-26.6%
2007-12-31HK$35.53 M